Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.14 is 70% below its 5-year average of 7.15, near the low end of its 5-year range (0.89–15.56).
As of the fiscal period ended Tuesday, June 30, 2026. 15.16% below its 12-month average of 2.53.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.14.
CURRENT RATIO
2.14
CURRENT RATIO AVG TTM
2.53
CURRENT RATIO AVG 3Y
4.18
CURRENT RATIO AVG 5Y
7.15
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.16%
CURRENT VS 3Y AVG
-48.69%
CURRENT VS 5Y AVG
-70.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-42.84%
vs the sector median at left
Market Cap
$6.62M
Current Ratio
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
Market Cap
$6.53M
Current Ratio
0.70
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.04
Market Cap
$5.89M
Current Ratio
119.39
TTM Avg
100.04
3Y Avg
53.39
5Y Avg
40.10
Market Cap
$5.89M
Current Ratio
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Femasys Inc. (FEMY) | $6.28M | 2.14 | 2.53 | 4.18 | 7.15 |
| Biomerica, Inc. (BMRA)vs › | $6.27M | 1.62 | 2.21 | 3.63 | 4.38 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.62M | 10.21 | 3.61 | 3.34 | 4.20 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.53M | 0.70 | 2.00 | 1.31 | 1.04 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.89M | 119.39 | 100.04 | 53.39 | 40.10 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.89M | 17.15 | 11.86 | 7.50 | 9.06 |
| Scienture Holdings, Inc. (SCNX)vs › | $5.94M | 3.04 | 1.85 | 1.23 | 3.43 |
| Aclarion, Inc. (ACON)vs › | $6.70M | 16.20 | 7.76 | 4.60 | 3.08 |
| Lucyd, Inc (LUCY)vs › | $5.86M | 12.06 | 10.77 | 9.40 | 6.47 |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.79M | 2.99 | 2.79 | 3.17 | 3.10 |
Current Ratio
2.14
Quick Ratio
0.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.14 |
| 2026-03-31 | 3.91 |
| 2025-12-31 | 4.53 |
| 2025-09-30 | 1.16 |
| 2025-06-30 | 0.89 |
| 2025-03-31 | 0.93 |
| 2024-12-31 | 0.93 |
| 2024-09-30 | 3.94 |
| 2024-06-30 | 6.47 |
| 2024-03-31 | 8.43 |
| 2023-12-31 | 7.59 |
| 2023-09-30 | 4.68 |
| 2023-06-30 | 8.71 |
| 2023-03-31 | 8.02 |
| 2022-12-31 | 9.25 |
| 2022-09-30 | 9.57 |
| 2022-06-30 | 10.90 |
| 2022-03-31 | 13.93 |
| 2021-12-31 | 15.15 |
| 2021-09-30 | 15.56 |
| 2021-06-30 | 13.38 |
| 2021-03-31 | 0.64 |
| 2020-12-31 | 1.34 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
